A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting
NCT ID: NCT05094128
Last Updated: 2025-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
352 participants
OBSERVATIONAL
2021-11-22
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Upadacitinib is being developed for the treatment of axSpA. Approximately 352 adult participants with active axSpA will be enrolled in Germany.
Participants will receive oral upadacitinib tablets as prescribed by the physician prior to enrolling in this study in accordance with the terms of the local marketing authorization and professional and reimbursement guidelines with regards to dose, population and indication. The overall duration of the study is approximately 52 weeks.
There may be a higher burden for participants in this study compared to usual standard of care due to study procedures. Participants will attend regular visits per routine clinical practice. The effect of the treatment will be checked by medical assessments, checking for side effects, and questionnaires.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the Change in Early and Sustained Pain Control in Axial Spondylarthritis in Adult Participants Receiving Upadacitinib
NCT04846244
A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis
NCT04169373
A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis
NCT03178487
Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis
NCT07018206
Study of Adalimumab in Patients With Axial Spondyloarthritis
NCT00939003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants Receiving Upadacitinib.
Upadacitinib
Tablet; Oral
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Upadacitinib
Tablet; Oral
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Physician decision on participant treatment with upadacitinib must have been reached prior to and independently of recruitment in the study.
* Upadacitinib prescribed in accordance with the local label.
Exclusion Criteria
* Participants with primary fibromyalgia (upon physician´s judgement)
* Participation in a clinical trial of an investigational drug, concurrently or within the last 30 days or five half-lives of the drug (whichever is longer) prior to the first dose of study drug or is currently enrolled in another clinical study.
* Participants who cannot be treated with upadacitinib according to the applicable local label.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ABBVIE INC.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ACURA Rheumazentrum Baden-Bade /ID# 249751
Baden-Baden, Baden-Wurttemberg, Germany
Heilig, Heidelberg, DE /ID# 240492
Heidelberg, Baden-Wurttemberg, Germany
Rheumatologische Schwerpunktpraxis /ID# 245392
Stuttgart, Baden-Wurttemberg, Germany
Praxis Dr. Haas /ID# 242982
Tübingen, Baden-Wurttemberg, Germany
Praxis Dr. Rinaldi /ID# 242984
Ulm, Baden-Wurttemberg, Germany
Praxis K. Pagel /ID# 240490
Hoppegarten, Brandenburg, Germany
Rheumahaus Studien GbR, Potsdam, DE /ID# 245231
Potsdam, Brandenburg, Germany
Praxis Dr. Sabine Reckert /ID# 245142
Potsdam, Brandenburg, Germany
Fachpraxis fuer Rheumatologie und Osteologie /ID# 243358
Bruchhausen-Vilsen, Lower Saxony, Germany
Stille, Hanover, DE /ID# 252222
Hanover, Lower Saxony, Germany
Praxis. F. Bigdeli-Wilshusen /ID# 272904
Hanover, Lower Saxony, Germany
Medizinische Hochschule Hannover /ID# 262814
Hanover, Lower Saxony, Germany
Rheumatologie Kassel /ID# 275998
Kassel, Lower Saxony, Germany
Krankenhaus Porz am Rhein /ID# 243765
Cologne, North Rhine-Westphalia, Germany
Rheumazentrum Ruhrgebiet /ID# 240460
Herne, North Rhine-Westphalia, Germany
Beyer, Kaiserslautern, DE /ID# 240444
Kaiserslautern, Rhineland-Palatinate, Germany
Krankenhaus der Barmherzigen Brüder Trier /ID# 240524
Trier, Rhineland-Palatinate, Germany
Praxis Bernd Mueller /ID# 240488
Homburg, Saarland, Germany
Rheumapraxis Dr. Prothmann /ID# 240671
Püttlingen, Saarland, Germany
Medizinischen Versorgungszentrums Agilomed /ID# 240481
Chemnitz, Saxony, Germany
Hamann & Teich & Boche,Leipzig /ID# 240445
Leipzig, Saxony, Germany
Praxis internistische Rheumatologie /ID# 240515
Leipzig, Saxony, Germany
Praxis Dr. Liebhaber /ID# 240480
Halle, Saxony-Anhalt, Germany
Aurich & Sieburg, Magdeburg /ID# 240518
Magdeburg, Saxony-Anhalt, Germany
Rheumatologische Praxis Dr. Jochen Walter /ID# 250263
Rendsburg, Schleswig-Holstein, Germany
MVZ Ambulantes Rheumazentrum Erfurt /ID# 244448
Erfurt, Thuringia, Germany
Rheumapraxis Weimar /ID# 268387
Weimar, Thuringia, Germany
Kupka & Kupka, Altenburg, DE /ID# 240479
Altenburg, , Germany
Marycz, Amberg, DE /ID# 240483
Amberg, , Germany
Rheumapraxis am Webereck /ID# 240454
Augsburg, , Germany
Praxis S. Bresgulewski /ID# 240662
Bad Bertrich, , Germany
Kerckhoff Klinik /ID# 252219
Bad Nauheim, , Germany
Rheumapraxis Berlin /ID# 242987
Berlin, , Germany
Praxis Dr. med. Angela Seifert /ID# 245107
Berlin, , Germany
Praxis Dr. Silke Zinke /ID# 240526
Berlin, , Germany
Krankenhaus Waldfriede /ID# 268389
Berlin, , Germany
Eisterhues, Braunschweig, DE /ID# 239438
Braunschweig, , Germany
MVZ Herzogin Elisabeth Hospital /ID# 267983
Braunschweig, , Germany
Dr. Walberer /ID# 249752
Burglengenfeld, , Germany
Private Practice - Dr. Sebastian Schuh /ID# 240498
Coburg, , Germany
Dres. Karger/Baerlecken /ID# 240442
Cologne, , Germany
MVZ-Medizinisches Versorgungszentrum Daun GmbH /ID# 254839
Daun, , Germany
Kreiskrankenhaus Demmin /ID# 240451
Demmin, , Germany
Rheumatologisches MVZ Dresden /ID# 240516
Dresden, , Germany
Praxis Dilltal /ID# 240520
Ehringshausen, , Germany
Private Practice - Dr. Daniel Bestler /ID# 251860
Erfurt, , Germany
Michael Mueller, Freiberg, DE /ID# 240489
Freiberg, , Germany
Praxis Dres. Sensse/Sensse /ID# 240517
Gifhorn, , Germany
Dr. Heintz /ID# 254037
Hamburg, , Germany
Dres. Weinhardt/Knobel/Doepfer /ID# 248195
Hamburg, , Germany
Zentrum fuer Rheumatologie und Schmerzmedizin /ID# 244370
Hanover, , Germany
Wernicke, Hohen Neuendorf, DE /ID# 250626
Hohen Neuendorf, , Germany
Kremers, Juelich, DE /ID# 243357
Jülich, , Germany
Dr. Bolze, Ludwigshafen, DE /ID# 251012
Ludwigshafen, , Germany
Praxis Dr. Annekatrin Rossbach /ID# 240495
Mansfeld / Großörner, , Germany
Harmuth, Marktredwitz, DE /ID# 240455
Marktredwitz, , Germany
RHIO Forschungsinstitut /ID# 240525
Meerbusch, , Germany
Prof-med-stud.de /ID# 240458
Munich, , Germany
Rheumatologische Facharztpraxis /ID# 240477
Naumburg, , Germany
Praxis Dr. med Thilo Klopsch /ID# 240461
Neubrandenburg, , Germany
Praxis Hein & Gess /ID# 240456
Nienburg, , Germany
MVZ für Rheumatologie Dr. M. Welcker /ID# 240521
Planegg, , Germany
Baumann & Lang, Plauen, DE /ID# 244369
Plauen, , Germany
Rheumazentrum Ratingen /ID# 240465
Ratingen, , Germany
Melzer, Seesen, DE /ID# 240484
Seesen, , Germany
Barmherzige Bruder MVZ Klinikum Straubing GmbH /ID# 240523
Straubing, , Germany
Rheumathologie Ulm /ID# 240494
Ulm, , Germany
Praxis F. Schattenberg /ID# 257646
Waren (Müritz), , Germany
Krankenhaus St. Josef /ID# 249747
Wuppertal, , Germany
Praxis Barmen /ID# 240449
Wuppertal, , Germany
Praxis Barmen /ID# 277515
Wuppertal, , Germany
Fricke-Wagner, Zwickau, DE /ID# 240452
Zwickau, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
This clinical study may be evaluating a usage that is not currently FDA approved. Please see US Prescribing Information for approved uses.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P21-007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.